Skip to content

Analysis of GLP-1 in the FD patients with mosapride treatment

Analysis of GLP-1 in the FD patients with mosapride treatment - Analysis of GLP-1 in mosapride treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000009704
Enrollment
15
Registered
2013-01-06
Start date
2012-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional dyspepsia

Interventions

None listed

Sponsors

Chiba University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: FD with mosapride treatment

Exclusion criteria

Exclusion criteria: It depends on physicians judgement

Design outcomes

Primary

MeasureTime frame
GLP-1

Countries

Japan

Contacts

Public ContactMakoto Arai

Chiba University Gastroenterology

araim-cib@umin.ac.jp043-226-2083

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026